Zhixiang (Shanghai) Medical Technology

Zhixiang (Shanghai) Medical Technology, operating under the brand Zhixiang Biologics, is a specialized Contract Development and Manufacturing Organization (CDMO) focused on the biologics sector. Founded in 2018, the company provides comprehensive end-to-end services including cell line development, bioprocess optimization, and large-scale GMP manufacturing for therapeutic proteins and antibodies. Zhixiang operates advanced facilities in Shanghai and Suzhou, utilizing state-of-the-art single-use bioreactor technologies to support global biopharmaceutical clients. Their technical expertise covers complex modalities such as bispecific antibodies and recombinant fusion proteins, aiming to reduce costs and accelerate time-to-market for innovative therapies. The company is led by industry veterans with extensive experience in global biologics manufacturing and regulatory compliance.